BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12368197)

  • 1. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
    Favier J; Plouin PF; Corvol P; Gasc JM
    Am J Pathol; 2002 Oct; 161(4):1235-46. PubMed ID: 12368197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.
    Salmenkivi K; Heikkilä P; Liu J; Haglund C; Arola J
    APMIS; 2003 Apr; 111(4):458-64. PubMed ID: 12780519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing.
    Baatar D; Jones MK; Tsugawa K; Pai R; Moon WS; Koh GY; Kim I; Kitano S; Tarnawski AS
    Am J Pathol; 2002 Oct; 161(4):1449-57. PubMed ID: 12368217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.
    Marti HJ; Bernaudin M; Bellail A; Schoch H; Euler M; Petit E; Risau W
    Am J Pathol; 2000 Mar; 156(3):965-76. PubMed ID: 10702412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.
    Favier J; Igaz P; Burnichon N; Amar L; Libé R; Badoual C; Tissier F; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    Endocr Pathol; 2012 Mar; 23(1):34-42. PubMed ID: 22183643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
    Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
    Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
    Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma.
    Xia G; Kageyama Y; Hayashi T; Kawakami S; Yoshida M; Kihara K
    Cancer; 2001 Apr; 91(8):1429-36. PubMed ID: 11301389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
    Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
    Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.
    Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
    Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma.
    Nakayama K; Kanzaki A; Hata K; Katabuchi H; Okamura H; Miyazaki K; Fukumoto M; Takebayashi Y
    Cancer Lett; 2002 Feb; 176(2):215-23. PubMed ID: 11804750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure.
    Koshikawa N; Iyozumi A; Gassmann M; Takenaga K
    Oncogene; 2003 Oct; 22(43):6717-24. PubMed ID: 14555985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.